Osteosarcopenic obesity in cardiovascular patients. Controversial and open issues

See “Inflammaging in the pathogenesis of chronic non-communicable diseases”, Kim O. T. in Opinion of invited editor, pp. 54-55.The study of osteosarcopenic obesity (OSO) in patients with cardiovascular diseases (CVDs) in recent years has caused a dis-cussion on common pathogenesis of atherosclerosis...

Full description

Bibliographic Details
Main Authors: K. E. Krivoshapova, V. L. Masenko, E. D. Bazdyrev, O. L. Barbarash
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2021-10-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/2787
_version_ 1797882350591279104
author K. E. Krivoshapova
V. L. Masenko
E. D. Bazdyrev
O. L. Barbarash
author_facet K. E. Krivoshapova
V. L. Masenko
E. D. Bazdyrev
O. L. Barbarash
author_sort K. E. Krivoshapova
collection DOAJ
description See “Inflammaging in the pathogenesis of chronic non-communicable diseases”, Kim O. T. in Opinion of invited editor, pp. 54-55.The study of osteosarcopenic obesity (OSO) in patients with cardiovascular diseases (CVDs) in recent years has caused a dis-cussion on common pathogenesis of atherosclerosis, obesity, progressive loss of skeletal and muscle mass. Are these processes independent age-related conditions or comorbidities with common links of pathogenesis? The aim of this review was to analyze studies on OSO in patients with CVDs. We used following electronic databases: PubMed, Clinical Trials, Google Scholar, www.elibrary.ru. Based on this analysis, modern ideas on the etiology, epidemiology and pathogenesis of OSO in elderly and senile patients with atherosclerosis were described. The authors concluded that absence of standards for OSO diagnosis and inadequate clinical suspicion of specialists during routine examination is one of the main causes of its insufficient detection in elderly patients with CVDs. The results of analyzed studies allow us to consider the OSO and atherosclerotic changes as a single link of cardiovascular continuum. Eliminating the negative effect of chronic inflammation on human body should be considered as a key mechanism in the treatment of OSO and atherosclerosis. However, more research is needed in this area.
first_indexed 2024-04-10T03:34:22Z
format Article
id doaj.art-b19a36d40fed4f64860a8101c1e873ac
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2024-04-10T03:34:22Z
publishDate 2021-10-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-b19a36d40fed4f64860a8101c1e873ac2023-03-13T07:23:31Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252021-10-0120610.15829/1728-8800-2021-27872327Osteosarcopenic obesity in cardiovascular patients. Controversial and open issuesK. E. Krivoshapova0V. L. Masenko1E. D. Bazdyrev2O. L. Barbarash3ФГБНУ Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеванийФГБНУ Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеванийФГБНУ Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеванийФГБНУ Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеванийSee “Inflammaging in the pathogenesis of chronic non-communicable diseases”, Kim O. T. in Opinion of invited editor, pp. 54-55.The study of osteosarcopenic obesity (OSO) in patients with cardiovascular diseases (CVDs) in recent years has caused a dis-cussion on common pathogenesis of atherosclerosis, obesity, progressive loss of skeletal and muscle mass. Are these processes independent age-related conditions or comorbidities with common links of pathogenesis? The aim of this review was to analyze studies on OSO in patients with CVDs. We used following electronic databases: PubMed, Clinical Trials, Google Scholar, www.elibrary.ru. Based on this analysis, modern ideas on the etiology, epidemiology and pathogenesis of OSO in elderly and senile patients with atherosclerosis were described. The authors concluded that absence of standards for OSO diagnosis and inadequate clinical suspicion of specialists during routine examination is one of the main causes of its insufficient detection in elderly patients with CVDs. The results of analyzed studies allow us to consider the OSO and atherosclerotic changes as a single link of cardiovascular continuum. Eliminating the negative effect of chronic inflammation on human body should be considered as a key mechanism in the treatment of OSO and atherosclerosis. However, more research is needed in this area.https://cardiovascular.elpub.ru/jour/article/view/2787саркопенияостеопорозостеопенияожирениесердечно-сосудистые заболеванияатеросклерозпожилой возрастстарениеэтиологияэпидемиологияпатогенез
spellingShingle K. E. Krivoshapova
V. L. Masenko
E. D. Bazdyrev
O. L. Barbarash
Osteosarcopenic obesity in cardiovascular patients. Controversial and open issues
Кардиоваскулярная терапия и профилактика
саркопения
остеопороз
остеопения
ожирение
сердечно-сосудистые заболевания
атеросклероз
пожилой возраст
старение
этиология
эпидемиология
патогенез
title Osteosarcopenic obesity in cardiovascular patients. Controversial and open issues
title_full Osteosarcopenic obesity in cardiovascular patients. Controversial and open issues
title_fullStr Osteosarcopenic obesity in cardiovascular patients. Controversial and open issues
title_full_unstemmed Osteosarcopenic obesity in cardiovascular patients. Controversial and open issues
title_short Osteosarcopenic obesity in cardiovascular patients. Controversial and open issues
title_sort osteosarcopenic obesity in cardiovascular patients controversial and open issues
topic саркопения
остеопороз
остеопения
ожирение
сердечно-сосудистые заболевания
атеросклероз
пожилой возраст
старение
этиология
эпидемиология
патогенез
url https://cardiovascular.elpub.ru/jour/article/view/2787
work_keys_str_mv AT kekrivoshapova osteosarcopenicobesityincardiovascularpatientscontroversialandopenissues
AT vlmasenko osteosarcopenicobesityincardiovascularpatientscontroversialandopenissues
AT edbazdyrev osteosarcopenicobesityincardiovascularpatientscontroversialandopenissues
AT olbarbarash osteosarcopenicobesityincardiovascularpatientscontroversialandopenissues